Insider Trading & Ownership of Hannah Valantine
-
Location
-
Menlo Park, CA
-
Summary
-
The estimated net worth of Hannah Valantine is at least $1,358,178 dollars as of 12 Mar 2026. Hannah Valantine is the Director of CareDx, Inc. and owns shares of CareDx, Inc. (CDNA) stock worth about $747.3K. Hannah Valantine is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $564.6K. Hannah Valantine is the Director of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. and owns shares of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) stock worth about $46.3K.
-
Signature
-
/s/ Will Solis, Attorney-in-Fact
Follow Filing Activity
Follow Hannah Valantine and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Hannah Valantine has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,358,178.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: CareDx, Inc. ($747,288).
- Past-year value change for that position: -$202,566.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Hannah Valantine
Insider Transactions Reported by Hannah Valantine:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.